about
Use of bortezomib as anti-humoral therapy in kidney transplantation.Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients.Prediction of clinical outcomes after kidney transplantation from deceased donors with acute kidney injury: a comparison of the KDIGO and AKIN criteria.The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients.Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study.Clinical effects of pre-transplant serum 25-hydroxyvitamin D level on post-transplant immunologic and non-immunologic outcomes in kidney transplant recipients.Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: the urologist's perspective.The impact of kidney transplantation on 24-hour ambulatory blood pressure in end-stage renal disease patients.Clinical significance of CCR7+CD8+ T cells in kidney transplant recipients with allograft rejection.Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort studyValidation Study of an Operational Tolerance Signature in Korean Kidney Transplant RecipientsEndocan as a marker of microvascular inflammation in kidney transplant recipientsImpact of acute kidney injury in expanded criteria deceased donors on post-transplant clinical outcomes: multicenter cohort studyClinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.Therapeutic potential of coenzyme Q10 in mitochondrial dysfunction during tacrolimus-induced beta cell injury.Impact of acute kidney injury in elderly versus young deceased donors on post-transplant outcomes: A multicenter cohort studyClinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipientsChanging pattern and safety of pretransplant malignancy in kidney transplant recipientsRole of Klotho in Chronic Calcineurin Inhibitor NephropathyClinical outcomes of kidney transplantation in older end-stage renal disease patients: A nationwide cohort studyUse of mesenchymal stem cells for chronic kidney diseaseThe impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumoniaImpact of Kidney Donor Profile Index Scores on Post-Transplant Clinical Outcomes Between Elderly and Young Recipients, A Multicenter Cohort StudyDevelopment of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of LiteratureThe differential effects of anemia on mortality in young and elderly end-stage renal disease patientsPhenotype and molecular signature of CD8+ T cell subsets in T cell- mediated rejections after kidney transplantation
P50
Q33627580-9B455467-0AA4-4C00-BE0A-B908511C3EA0Q36134073-F429F237-9D58-4EA9-A4CD-B217D5E0B609Q36262903-78ECA0DD-4C92-4329-9C8D-11159A08114CQ37704938-3A3C94BB-3364-4AFA-85C2-C541036E6815Q40217293-D574DBA5-7C5E-446E-95A1-8B1141B5C69EQ40441830-114EF701-428E-4FF4-8E81-DB8508124178Q40830549-C928DE8F-560D-44F1-80BC-5746F361D664Q53475210-18A37DEE-82C5-4300-8DC7-7201C4CC80FCQ55401748-52843E5F-9699-48F6-9DD1-F26FE3AAA5A4Q56985492-6A9E3567-09C5-4B41-88CE-7D81D8EFC4E7Q58574465-1FAB29AA-2B31-42D1-97BA-38D2597456C0Q61796690-985F0447-BB94-45D0-9D38-3929F0352952Q61799791-BE8D10E8-64D1-4BF7-94F7-367B69DD656CQ64956036-46F730C2-2F90-4E3B-9DBC-88D889C5D3C2Q64996291-D7A4B1F2-19A2-4C72-8D64-66D80FFBC968Q89948231-48E70A88-B94E-4490-94D7-2900DB82483EQ90242167-D3A0B789-4180-47C1-BA23-B283D7F1118BQ90878316-CD37D2BD-3BAA-43A6-AE6B-F5B7A811A8BEQ91476847-81228D03-167A-4B24-A7ED-81EDD28AE815Q91787466-04ADC275-CDBE-4B03-8A5D-95F1E7F1D254Q92686672-5C3F82DE-D15D-4A41-B520-1748CBB02315Q93026473-E89D7D8F-C531-46ED-941C-BC1C52CA07D3Q93216885-201EB595-4BFA-4189-ADBE-A8FD3CBB76DEQ94958567-E9B5155B-AD2B-4633-B3A9-F35BD801B97AQ95839495-7D4342B4-263C-4CBA-A1AD-F63CA7AA46A0Q96341864-581DA345-EAEF-42C6-9DF7-FCC5A3810ADA
P50
description
investigador
@es
researcher
@en
name
Byung Ha Chung
@en
type
label
Byung Ha Chung
@en
prefLabel
Byung Ha Chung
@en
P31
P496
0000-0003-0048-5717